1. Age-related immunogenicity and reactogenicity of live oral cholera vaccine CVD 103-HgR in a randomized, controlled clinical trial. Issue 11 (7th March 2019) Authors: McCarty, James M.; Lock, Michael D.; Bennett, Sean; Hunt, Kristin M.; Simon, Jakub K.; Gurwith, Marc Journal: Vaccine Issue: Volume 37:Issue 11(2019) Page Start: 1389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection. Issue 20 (11th May 2018) Authors: Haney, Douglas J.; Lock, Michael D.; Gurwith, Marc; Simon, Jakub K.; Ishioka, Glenn; Cohen, Mitchell B.; Kirkpatrick, Beth D.; Lyon, Caroline E.; Chen, Wilbur H.; Sztein, Marcelo B.; Levine, Myron M.; Harris, Jason B. Journal: Vaccine Issue: Volume 36:Issue 20(2018) Page Start: 2768 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR in healthy adults age 18–45. Issue 6 (1st February 2018) Authors: McCarty, James M.; Lock, Michael D.; Hunt, Kristin M.; Simon, Jakub K.; Gurwith, Marc Journal: Vaccine Issue: Volume 36:Issue 6(2018) Page Start: 833 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗